Inventor

HILLEN HEINZ

DE30 patents

⚠️ This page may combine multiple inventors who share the name “HILLEN HEINZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HILLEN HEINZ

BASF AG

Proteins and the preparation thereof

Proteins having a tnf action comprising tnf-fibromectin fusion protein

Low molecular weight inhibitors of complement proteases

Purification of hTNF

Endothelin converting enzyme (ECE)

Recombinant fibrinogenases, the preparation and use thereof

N-terminal deletions of lymphotoxin, their preparation and use

Carboxylic acid derivatives, their production and use

BARGHORN STEFAN

Anti-Aβ globulomer 5F7 antibodies

Amyloid-beta binding proteins

Amyloid-beta binding proteins

Aβ conformer selective anti-aβ globulomer monoclonal antibodies

Aβ conformer selective anti-Aβ globulomer monoclonal antibodies

ABBVIE INC

Abeta conformer selective anti-Abeta globulomer monoclonal antibodies

Anti-Aβ globulomer 4D10 antibodies

Monoclonal antibodies against amyloid beta protein and uses thereof

Aβ conformer selective anti-Aβ globulomer monoclonal antibodies

Anti-Aβ globulomer 7C6 antibodies

ABBVIE DEUTSCHLAND

Aβ conformer selective anti-Aβ globulomer monoclonal antibodies

Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof

Amyloid-beta binding proteins

Amyloid-beta binding proteins

HILLEN HEINZ

Amyloid-beta globulomer antibodies

Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof

Monoclonal antibodies against amyloid beta protein and uses thereof

ABBOTT LAB

Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists

Pharmaceutically active compounds, their preparation and use as ECE-inhibitors

ABBOTT GMBH & CO KG

Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof

HOLZMAN THOMAS F

Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins

NIMMRICH VOLKER

Method for the treatment of amyloidoses